dihydroxyphenylalanine has been researched along with Malignant Carcinoid Syndrome in 10 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
COLLINI, FJ | 1 |
SJOERDSMA, A | 1 |
OATES, JA | 1 |
ZALTZMAN, P | 1 |
UDENFRIEND, S | 1 |
DAVIS, RB | 1 |
ALEXANDER, CS | 1 |
ADICOFF, A | 1 |
DUBACH, UC | 1 |
BLUMBERG, A | 1 |
WELTI, JJ | 1 |
DREUX, C | 1 |
BONVARLET, A | 1 |
SAVIER, CH | 1 |
DUHAMEL, J | 1 |
NICHOLSON, GI | 1 |
IRVINE, RO | 1 |
NOBLE, NR | 1 |
Koopmans, KP | 1 |
Brouwers, AH | 1 |
De Hooge, MN | 1 |
Van der Horst-Schrivers, AN | 1 |
Kema, IP | 1 |
Wolffenbuttel, BH | 1 |
De Vries, EG | 1 |
Jager, PL | 1 |
Nataf, V | 1 |
Balard, M | 1 |
de Beco, V | 1 |
Kerrou, K | 1 |
Gutman, F | 1 |
Grahek, D | 1 |
Montravers, F | 1 |
Talbot, JN | 1 |
Feldman, JM | 1 |
Butler, SS | 1 |
Chapman, BA | 1 |
10 other studies available for dihydroxyphenylalanine and Malignant Carcinoid Syndrome
Article | Year |
---|---|
Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.
Topics: Dihydroxyphenylalanine; Disease Management; Humans; Lyases; Malignant Carcinoid Syndrome; Methyldopa | 1961 |
Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Mal | 1960 |
Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.
Topics: Dihydroxyphenylalanine; Humans; Isoniazid; Malignant Carcinoid Syndrome; Methyldopa; Serotonin; Tryp | 1961 |
[On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa | 1961 |
[Trial treatment of 2 cases of carcinoid syndrome with alpha-methyl-dopa].
Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa | 1962 |
Effect of methyldopa in carcinoid disease.
Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Malignant Carcinoid Synd | 1962 |
A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa | 1961 |
Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.
Topics: Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Liver N | 2005 |
Safety of 18F-DOPA injection for PET of carcinoid tumor.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Injections, Intravenous; Ma | 2006 |
Interference with measurement of 3-methoxy-4-hydroxymandelic acid and 5-hydroxyindoleacetic acid by reducing metabolites.
Topics: Aged; Alkaptonuria; Aspirin; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Humans; Indoleacetic A | 1974 |